28
Participants
Start Date
October 31, 2003
Primary Completion Date
March 31, 2008
Study Completion Date
March 31, 2008
Pergolide
"0,3 mg pergolide (the first two days begin with 0,05mg, then increase of dose of 0,1mg every 3 days for a maximum of 0,3mg/d, taken orally 3x 0,1mg/day). Then stable dose of 0,3mg for one week.. Subsequently slow (for 8 days) reduction of dosage of 0,1mg every 3 days for 6 days then 0,05mg every day for the last two days.~Placebo group is identical in appearance and number of placebo capsules, in the same starting and maintenance scheme as for the pergolide group."
Universitätsklinikum Hamburg - Eppendorf, Hamburg
Psychiatrische Universitätsklinik, Heidelberg
SRH Klinikum Karlsbad - Langensteinbach gGmbH, Karlsbad
Zentralinstitut für Seelische Gesundheit, Mannheim
Stanley Medical Research Institute
OTHER
Heidelberg University
OTHER